Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 09, 2021

SELL
$144.0 - $169.39 $211,248 - $248,495
-1,467 Closed
0 $0
Q4 2020

Jan 12, 2021

BUY
$157.07 - $174.35 $4,397 - $4,881
28 Added 1.95%
1,467 $243,000
Q3 2020

Oct 08, 2020

SELL
$137.1 - $165.37 $37,428 - $45,146
-273 Reduced 15.95%
1,439 $238,000
Q1 2020

Apr 09, 2020

SELL
$92.66 - $144.94 $11,675 - $18,262
-126 Reduced 6.86%
1,712 $201,000
Q3 2019

Oct 11, 2019

BUY
$112.57 - $128.43 $8,105 - $9,246
72 Added 4.08%
1,838 $229,000
Q2 2019

Jul 19, 2019

BUY
$97.98 - $114.28 $173,032 - $201,818
1,766 New
1,766 $200,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Abner Herrman & Brock LLC Portfolio

Follow Abner Herrman & Brock LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abner Herrman & Brock LLC with notifications on news.